PAIM
AGN

Punch & Associates Investment Management’s Allergan plc AGN Stock Holding History

Punch & Associates Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-19,668
Closed -$4.03M – 189
2017
Q3 		$4.03M Sell
19,668
-95
-0.5% -$22.1K 0.36% 116
2017
Q2 		$4.8M Buy
+19,763
New +$4.64M 0.45% 97

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Punch & Associates Investment Management's AGN Position: Q4 2017 in Review

Punch & Associates Investment Management sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 19,668 shares — an estimated $4.03M sold.

Punch & Associates Investment Management first reported a position in AGN in Q2 2017 and held it in 2 quarters. The position peaked at $4.8M in Q2 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Punch & Associates Investment Management reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Punch & Associates Investment Management sold 19,668 Allergan plc shares in Q4 2017, an estimated $4.03M.
  • Punch & Associates Investment Management first reported a position in Allergan plc in Q2 2017 and held it in 2 quarters.
  • Punch & Associates Investment Management's Allergan plc position peaked at $4.8M in Q2 2017.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Punch & Associates Investment Management's 13F filing for Q4 2017, filed 14 Feb 2018.